Cost-Effectiveness of Empagliflozin (Jardiance®) In The Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) In Turkey Based Empa-Reg Outcome Data
Autor: | A Temizhan, Ergun Oksuz, Y. Balbay, R. Ersoy, E. Tetik, E. Kamaci, B. Urganci, Simten Malhan |
---|---|
Rok vydání: | 2017 |
Předmět: |
medicine.medical_specialty
business.industry Cost effectiveness Health Policy Public Health Environmental and Occupational Health Type 2 Diabetes Mellitus 030209 endocrinology & metabolism 030204 cardiovascular system & hematology 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine chemistry Internal medicine Empagliflozin Medicine Outcome data business EMPA |
Zdroj: | Value in Health. 20:A479 |
ISSN: | 1098-3015 |
Databáze: | OpenAIRE |
Externí odkaz: |